Patient samples are a useful tool for discovering disease genetics, but obtaining them is a lengthy process. DNA Sciences Inc. believes it will save time with its purchase of PPGx Inc., which will provide a bolus of existing samples to the combined company. DNA Sciences, which is developing gene-based clinical tools that it plans to market to physicians